The Role of SARS-CoV-2 N Protein in Diagnosis and Vaccination in the Context of Emerging Variants: Present Status and Prospects

Overview

Journal Front Microbiol

Specialty Microbiology

Date 2023 Sep 7

PMID 37675423

Authors

Wanchen Song

Zhongbiao Fang

Feike Ma

Jiaxuan Li

Zhiwei Huang

Yanjun Zhang

Jianhua Li

Keda Chen

Affiliations

Soon will be listed here.

Abstract

Despite many countries rapidly revising their strategies to prevent contagions, the number of people infected with Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to surge. The emergent variants that can evade the immune response significantly affect the effectiveness of mainstream vaccines and diagnostic products based on the original spike protein. Therefore, it is essential to focus on the highly conserved nature of the nucleocapsid protein as a potential target in the field of vaccines and diagnostics. In this regard, our review initially discusses the structure, function, and mechanism of action of N protein. Based on this discussion, we summarize the relevant research on the in-depth development and application of diagnostic methods and vaccines based on N protein, such as serology and nucleic acid detection. Such valuable information can aid in designing more efficient diagnostic and vaccine tools that could help end the SARS-CoV-2 pandemic.

Citing Articles

Immunological assessment of NSFu1: A novel fusion molecule constructed from structural proteins of SARS-CoV-2 for improving COVID-19 antibody detection.

Arif S, Akhter M, Anwar A, Javaid S, Ashi Z, Shad M Arch Microbiol. 2025; 207(4):88.

PMID: 40088274 DOI: 10.1007/s00203-025-04286-3.

Immunoassay Detection of SARS-CoV-2 Using Monoclonal Antibody Binding to Viral Nucleocapsid Protein.

Hnasko R, Lin A, McGarvey J, Jackson E Microb Biotechnol. 2025; 18(2):e70117.

PMID: 39989430 PMC: 11848557. DOI: 10.1111/1751-7915.70117.

Cattle, sheep, and goat humoral immune responses against SARS-CoV-2.

Ardalan M, Cool K, Gaudreault N, Bold D, Mannix A, Hanzlicek G Vet Anim Sci. 2024; 26():100408.

PMID: 39619867 PMC: 11607650. DOI: 10.1016/j.vas.2024.100408.

Loop-Mediated Isothermal Amplification (LAMP): An Innovative Approach for the Environmental Monitoring of SARS-CoV-2.

Spiteri S, Marino F, Girolamini L, Pascale M, Derelitto C, Caligaris L Pathogens. 2024; 13(11).

PMID: 39599574 PMC: 11597229. DOI: 10.3390/pathogens13111022.

Selection and characterization of human scFvs targeting the SARS-CoV-2 nucleocapsid protein isolated from antibody libraries of COVID-19 patients.

Lisi S, Malerba F, Quaranta P, Florio R, Vitaloni O, Monaca E Sci Rep. 2024; 14(1):15864.

PMID: 38982108 PMC: 11233501. DOI: 10.1038/s41598-024-66558-0.

References

Okada M, Takemoto Y, Okuno Y, Hashimoto S, Yoshida S, Fukunaga Y . The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice. Vaccine. 2005; 23(17-18):2269-72. PMC: 7115605. DOI: 10.1016/j.vaccine.2005.01.036. View

Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y . Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019. Clin Infect Dis. 2020; 71(16):2027-2034. PMC: 7184337. DOI: 10.1093/cid/ciaa344. View

Farfour E, Asso-Bonnet M, Vasse M . The ID NOW COVID-19, a high-speed high-performance assay. Eur J Clin Microbiol Infect Dis. 2021; 40(9):2041-2045. PMC: 8046641. DOI: 10.1007/s10096-021-04243-0. View

Surjit M, Lal S . The SARS-CoV nucleocapsid protein: a protein with multifarious activities. Infect Genet Evol. 2007; 8(4):397-405. PMC: 7106238. DOI: 10.1016/j.meegid.2007.07.004. View

Lopez-Munoz A, Kosik I, Holly J, Yewdell J . Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive immunity. Sci Adv. 2022; 8(31):eabp9770. PMC: 9348789. DOI: 10.1126/sciadv.abp9770. View

Frank F, Keen M, Rao A, Bassit L, Liu X, Bowers H . Deep mutational scanning identifies SARS-CoV-2 Nucleocapsid escape mutations of currently available rapid antigen tests. Cell. 2022; 185(19):3603-3616.e13. PMC: 9420710. DOI: 10.1016/j.cell.2022.08.010. View

Aran D, Beachler D, Lanes S, Overhage J . Prior presumed coronavirus infection reduces COVID-19 risk: A cohort study. J Infect. 2020; 81(6):923-930. PMC: 7590640. DOI: 10.1016/j.jinf.2020.10.023. View

Bert N, Tan A, Kunasegaran K, Tham C, Hafezi M, Chia A . SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020; 584(7821):457-462. DOI: 10.1038/s41586-020-2550-z. View

Almeida L, Goncalves A, Franco-Luiz A, de Souza Silva T, Augusto Alves P, Lima do Monte-Neto R . Molecular detection of omicron SARS-CoV-2 variant is achieved by RT-LAMP despite genomic mutations. Mem Inst Oswaldo Cruz. 2022; 117:e220050. PMC: 9219828. DOI: 10.1590/0074-02760220050. View

10.

Sette A, Crotty S . Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021; 184(4):861-880. PMC: 7803150. DOI: 10.1016/j.cell.2021.01.007. View

11.

Chen Y, Han Y, Yang J, Ma Y, Li J, Zhang R . Impact of SARS-CoV-2 Variants on the Analytical Sensitivity of rRT-PCR Assays. J Clin Microbiol. 2022; 60(4):e0237421. PMC: 9020341. DOI: 10.1128/jcm.02374-21. View

12.

Osterman A, Iglhaut M, Lehner A, Spath P, Stern M, Autenrieth H . Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern. Med Microbiol Immunol. 2021; 210(5-6):263-275. PMC: 8377707. DOI: 10.1007/s00430-021-00719-0. View

13.

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

14.

Diao B, Wen K, Zhang J, Chen J, Han C, Chen Y . Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection. Clin Microbiol Infect. 2020; 27(2):289.e1-289.e4. PMC: 7534827. DOI: 10.1016/j.cmi.2020.09.057. View

15.

Rao A, Westbrook A, Bassit L, Parsons R, Fitts E, Greenleaf M . Sensitivity of rapid antigen tests against SARS-CoV-2 Omicron and Delta variants. J Clin Microbiol. 2023; 61(10):e0013823. PMC: 10654096. DOI: 10.1128/jcm.00138-23. View

16.

Fragkou P, Moschopoulos C, Dimopoulou D, Ong D, Dimopoulou K, Nelson P . Performance of point-of care molecular and antigen-based tests for SARS-CoV-2: a living systematic review and meta-analysis. Clin Microbiol Infect. 2022; 29(3):291-301. PMC: 9660861. DOI: 10.1016/j.cmi.2022.10.028. View

17.

Brosseau L, Escandon K, Ulrich A, Rasmussen A, Roy C, Bix G . Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Dose, Infection, and Disease Outcomes for Coronavirus Disease 2019 (COVID-19): A Review. Clin Infect Dis. 2021; 75(1):e1195-e1201. PMC: 8524637. DOI: 10.1093/cid/ciab903. View

18.

Prince-Guerra J, Almendares O, Nolen L, Gunn J, Dale A, Buono S . Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites - Pima County, Arizona, November 3-17, 2020. MMWR Morb Mortal Wkly Rep. 2021; 70(3):100-105. PMC: 7821766. DOI: 10.15585/mmwr.mm7003e3. View

19.

Brihn A, Chang J, OYong K, Balter S, Terashita D, Rubin Z . Diagnostic Performance of an Antigen Test with RT-PCR for the Detection of SARS-CoV-2 in a Hospital Setting - Los Angeles County, California, June-August 2020. MMWR Morb Mortal Wkly Rep. 2021; 70(19):702-706. PMC: 8118154. DOI: 10.15585/mmwr.mm7019a3. View

20.

Igakura T, Stinchcombe J, Goon P, Taylor G, Weber J, Griffiths G . Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science. 2003; 299(5613):1713-6. DOI: 10.1126/science.1080115. View